Biotechnology News

March 15, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced that Théa has fully deployed OneKey™, the world-leading healthcare professional (HCP) database, across its European business units in Norway, Finland, Denmark, Sweden, Turkey...

March 15, 2012

MANASSAS, Va. & CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--ATCC and U.VA. collaborate to foster biotech discovery. The innovative partnership will fund postdoctoral research in the biosciences.

March 15, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the Deferred Prosecution Agreement (DPA...

March 15, 2012

SKANEATELES FALLS, N.Y.--(BUSINESS WIRE)--Welch Allyn today announced it has appointed Stephen F. Meyer president and chief executive officer, effective April 16, 2012.

March 15, 2012

WASHINGTON--(BUSINESS WIRE)--Biofuel and renewable chemical company executives along with consumer product companies seeking partnerships in the renewable sector will be featured at BIO’s 9th annual World Congress on Industrial Biotechnology and...

March 15, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets....

March 15, 2012

NEW YORK--(BUSINESS WIRE)--IntelliCell BioSciences, Inc. (OTCQB: SVFC.PK) (PINKSHEETS: SVFC.PK) announces Ray Dirks Research Article published on www.CPreports.com . In an update to...

March 15, 2012

MILAN--(BUSINESS WIRE)--Revenues of €743.4 million, a 1.0% increase; Gross profit of €447.6 million, 60.2% of revenues; EBITDA of €128.7 million 7.3% of revenues; Net profit up 48.5% to €58.0 million, 7.8% of revenues

March 15, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) points out the important role for Cell-in-a-Box® technology, the medical community and treatment of solid tumors.

March 15, 2012

BRAMPTON, Ontario & MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced that it has received from Health Canada a license for Medtronic Deep Brain Stimulation (DBS) Therapy for refractory epilepsy patients. Medtronic DBS...

March 15, 2012

WASHINGTON--(BUSINESS WIRE)--Biopharmaceutical research companies are conducting or have conducted since 1999 nearly 4,400 clinical trials of new medicines in the state, a new report shows.

March 15, 2012

NASHUA, N.H. & MIAMI--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announced today the...

March 15, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Closes Deal with Game Changing Biotech Firm

March 15, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that preliminary testing shows that one of the molecules...

March 15, 2012

JERUSALEM & LUND, Sweden--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) today announced the publication of results from the laquinimod Phase III ALLEGRO study in the March 15...

March 15, 2012

WHITEHOUSE STATION, N.J. & SAN DIEGO--(BUSINESS WIRE)--Merck, known outside the United States and Canada as MSD, today announced a collaboration to create the California Institute for Biomedical Research (Calibr), an independent, not-for-...

March 15, 2012

HINGHAM, Mass.--(BUSINESS WIRE)--Phase One Medical, L.L.C. announced today that Pelham Plastics, a medical device manufacturer located in Pelham, NH, has been contracted to produce the company’s new Reversus™ Hemodialysis Catheter. Intended to...

March 15, 2012

MALVERN, Pa.--(BUSINESS WIRE)--TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the appointment of C. Glenn Begley, PhD, F.R.A.C.P., F.R.C.P.A., F.R.C.Path...

March 15, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported the financial results for the year ended December 31,...

March 15, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics Reports Final Fourth Quarter and Fiscal Year 2011 Results

March 15, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: An extraordinary general meeting (“EGM”) in Aerocrine AB (publ) (STO:AEROB) is held on Tuesday 10 April 2012 at 3.00 p.m. CET in the offices of Vinge, Smålandsgatan 20, Stockholm. Right to attend...

March 15, 2012

BASEL, Switzerland--(BUSINESS WIRE)--At a special launch press briefing on Tuesday 27 March, from 0900 -1030 at the Bella Center, Copenhagen, Jan Geissler, EUPATI Project Director, will present EUPATI and answer questions.

March 15, 2012

IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced...

March 15, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asia offers unique opportunities for the biopharmaceutical industry to transform and prosper, according to a white paper written by Amar Kureishi, Chief Medical Officer, Asia-Pacific, Quintiles.

March 14, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to revisions to footnote 2 of the Condensed Consolidated Statement of Operations. The corrected release reads: BIOTIME ANNOUNCES FOURTH QUARTER...

March 14, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--BioCardia, Inc. and Juventas Therapeutics announced today that they will continue to work together to execute Juventas’ Phase II trial of JVS-100 for the treatment of heart failure.

March 14, 2012

LYON, France--(BUSINESS WIRE)--Flamel Technologies (NASDAQ: FLML) today announced the acquisition of Éclat Pharmaceuticals, a specialty pharmaceutical company that is focused on the development, approval, and commercialization of niche brands and...

March 14, 2012

LYON, France--(BUSINESS WIRE)--Flamel Technologies (NASDAQ: FLML) today announced its financial results for the fourth quarter and year ended December 31, 2011. Separately, the Company also announced today that it has agreed to acquire Éclat...

March 14, 2012

SAN FRANCISCO--(BUSINESS WIRE)--AMS today shared a recent announcement from Mevion Medical Systems, Inc, regarding Mevion Medical Systems Receipt of CE Marking Certification for its MEVION S250 Proton Therapy System.

March 14, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that the underwriters of its previously announced public offering of common stock have exercised in full their overallotment option to purchase an...

March 14, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--PLoS ONE report on a targeted bactericidal protein against life-threatening E. coli O104 created using AvidBiotics’ antibacterial Purocin™ protein technology and draft genomic sequence data.

March 14, 2012

ALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc. (OTCBB: SNWV) today reported financial results and accomplishments for the year ended December 31, 2011, and provided an update on the U.S. Food and Drug Administration (FDA) status of the...

March 14, 2012

ORLANDO, Fla.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Thermo Scientific Easy-nLC 1000 has received a Scientist’s Choice Award from SelectScience, the leading online resource...

March 14, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq:AFFY) today reported financial results for the year ended December 31, 2011. The net loss for the year ended December 31, 2011 was $61.4 million compared to a net loss of $14.1 million for...

March 14, 2012

ZURICH & LUGANO, Switzerland & TORONTO--(BUSINESS WIRE)--EBD Group and SocialFinance.ca have joined together on behalf of Partnering for Global Impact® 2012 to deliver a live webinar on impact investing

March 14, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Nanotech Commercialization Conference (Durham, NC, April 4 - 5) to host "The Art of the Small" - a juried art exhibition of works inspired by nano tech, nano biotech, genomics, DNA and genetics.

March 14, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $675 million of its 3.125% Senior Notes due 2022 and $400 million of its 4.50% Senior Notes due 2042 (collectively, the "Notes"). Medtronic intends...

March 14, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Starkey Hearing Technologies is proud that its AMP hearing aid has been honored with a red dot award: product design 2012.

March 14, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced that Gedeon Richter Spain is deploying the award winning, pharma-specific Customer Relationship Management (CRM) solution, Mobile Intelligence™, via SaaS for their Specialty...

March 14, 2012

FREIENBACH, Switzerland--(BUSINESS WIRE)--FDA approves BINOSTO, First and Only Effervescent Osteoporosis Treatment in a Buffered Solution : Proven Fracture Risk Reduction of Alendronate at the Hip and Spine

March 14, 2012

LIBERTYVILLE, Ill.--(BUSINESS WIRE)--Valent BioSciences Corporation (VBC) announced today it signed a joint testing agreement with Pace International, LLC that will expand a screening and evaluation collaboration between the two companies into...

March 14, 2012

SAN BRUNO, Calif.--(BUSINESS WIRE)--Numerate announced a research collaboration with Merck focused on using proprietary algorithms and cloud computing to generate new small molecule drug leads against a cardiovascular disease target.

March 14, 2012

BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc., and its subsidiary American Renal Holdings Inc. announced results today for the quarter ended December 31, 2011. Financial and operating highlights include: Revenues –...

March 14, 2012

ANDOVER, Mass.--(BUSINESS WIRE)--Capsule is exhibiting at AONE 45th Annual Meeting and Exposition, March 21-24, 2012 in Boston for nurse leaders to discuss the benefits of medical device connectivity and its impact on patient care.

March 14, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.225 per ordinary share.

March 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on bringing environmentally sustainable solutions to the plastics, chemicals and energy industries, today announced that it has granted a non-...

March 14, 2012

BOSTON--(BUSINESS WIRE)--HighRes Biosolutions announces ACell, a brand new bench top laboratory automation system that’s small and safe enough for the bench top, yet flexible enough to integrate with HighRes' storage devices.

March 14, 2012

SAN MARINO, Calif.--(BUSINESS WIRE)--Cites Pre-IND Filing with FDA for Lyme Disease, Oncology &HIV Drugs in Pipeline, and Progress in Algal BioFuel Subsidiary, VG Energy